MZ
Therapeutic Areas
Innoviva Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TRELEGY ELLIPTA | COPD, Asthma | Commercial |
| ANORO ELLIPTA | COPD | Commercial |
| RELVAR/BREO ELLIPTA | Asthma, COPD | Commercial |
| Apramycin (TP-6076) | Serious Bacterial Infections (e.g., CRAB) | Phase 1 |
| AP-SA01/AP-SA02 | Staphylococcus aureus (MRSA) Infections | Phase 1b/2 |
| AP-PA01/AP-PA02 | Pseudomonas aeruginosa Infections | Phase 1b/2 |
| Phage Candidate | Mycobacterium abscessus Infections | Preclinical |
| Gepotidacin | uUTI, Uncomplicated Gonorrhea | NDA Submitted |